A detailed history of Charles Schwab Investment Management Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 250,346 shares of ANIP stock, worth $15.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250,346
Previous 241,477 3.67%
Holding current value
$15.5 Million
Previous $15.4 Million 2.87%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$54.33 - $65.72 $481,852 - $582,870
8,869 Added 3.67%
250,346 $14.9 Million
Q2 2024

Aug 12, 2024

BUY
$58.53 - $68.82 $2.63 Million - $3.1 Million
44,994 Added 22.9%
241,477 $15.4 Million
Q1 2024

May 08, 2024

BUY
$54.2 - $69.69 $2.68 Million - $3.44 Million
49,431 Added 33.61%
196,483 $13.6 Million
Q4 2023

Feb 06, 2024

BUY
$48.72 - $65.43 $3,069 - $4,122
63 Added 0.04%
147,052 $8.11 Million
Q3 2023

Nov 08, 2023

BUY
$50.28 - $64.61 $5.48 Million - $7.04 Million
109,015 Added 287.08%
146,989 $8.53 Million
Q2 2023

Aug 09, 2023

BUY
$37.29 - $53.83 $109,446 - $157,991
2,935 Added 8.38%
37,974 $2.04 Million
Q1 2023

May 11, 2023

BUY
$37.61 - $45.72 $14,442 - $17,556
384 Added 1.11%
35,039 $1.39 Million
Q4 2022

Feb 13, 2023

BUY
$31.9 - $41.95 $43,734 - $57,513
1,371 Added 4.12%
34,655 $1.39 Million
Q3 2022

Nov 14, 2022

BUY
$29.83 - $38.01 $18,255 - $23,262
612 Added 1.87%
33,284 $1.07 Million
Q2 2022

Aug 15, 2022

BUY
$23.09 - $33.46 $80,283 - $116,340
3,477 Added 11.91%
32,672 $970,000
Q1 2022

May 13, 2022

BUY
$26.91 - $47.15 $15,876 - $27,818
590 Added 2.06%
29,195 $821,000
Q4 2021

Feb 11, 2022

BUY
$32.97 - $56.85 $137,320 - $236,780
4,165 Added 17.04%
28,605 $1.32 Million
Q3 2021

Nov 16, 2021

SELL
$26.48 - $35.99 $1.19 Million - $1.61 Million
-44,853 Reduced 64.73%
24,440 $802,000
Q2 2021

Aug 16, 2021

BUY
$31.86 - $38.6 $317,038 - $384,108
9,951 Added 16.77%
69,293 $2.43 Million
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $136,774 - $174,050
-4,816 Reduced 7.51%
59,342 $2.15 Million
Q4 2020

Feb 16, 2021

BUY
$23.69 - $31.47 $23,382 - $31,060
987 Added 1.56%
64,158 $1.86 Million
Q3 2020

Nov 13, 2020

BUY
$26.38 - $33.1 $7,386 - $9,268
280 Added 0.45%
63,171 $1.78 Million
Q2 2020

Aug 14, 2020

BUY
$29.93 - $50.1 $133,757 - $223,896
4,469 Added 7.65%
62,891 $2.03 Million
Q1 2020

May 15, 2020

SELL
$30.35 - $67.14 $1.23 Million - $2.71 Million
-40,371 Reduced 40.86%
58,422 $2.38 Million
Q4 2019

Feb 07, 2020

BUY
$55.65 - $79.83 $60,102 - $86,216
1,080 Added 1.11%
98,793 $6.09 Million
Q3 2019

Nov 08, 2019

SELL
$64.7 - $85.39 $253,365 - $334,387
-3,916 Reduced 3.85%
97,713 $7.12 Million
Q2 2019

Aug 09, 2019

SELL
$67.77 - $82.2 $1.44 Million - $1.75 Million
-21,264 Reduced 17.3%
101,629 $8.35 Million
Q1 2019

May 14, 2019

BUY
$45.83 - $70.54 $114,345 - $175,997
2,495 Added 2.07%
122,893 $8.67 Million
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $600,793 - $823,628
14,593 Added 13.79%
120,398 $5.42 Million
Q3 2018

Nov 13, 2018

BUY
$52.95 - $71.34 $1.18 Million - $1.59 Million
22,229 Added 26.6%
105,805 $5.98 Million
Q2 2018

Aug 08, 2018

BUY
$56.38 - $68.08 $1.22 Million - $1.48 Million
21,700 Added 35.07%
83,576 $5.58 Million
Q1 2018

May 07, 2018

SELL
$56.98 - $72.41 $158,689 - $201,661
-2,785 Reduced 4.31%
61,876 $3.6 Million
Q4 2017

Jan 17, 2018

BUY
$53.3 - $74.56 $955,136 - $1.34 Million
17,920 Added 38.34%
64,661 $4.17 Million
Q3 2017

Nov 13, 2017

BUY
$43.46 - $52.49 $2.03 Million - $2.45 Million
46,741
46,741 $2.45 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.08B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.